Engflag

Cilex

Quick links to important sections

Cilex

There is no image.

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cilex

What is Cilex? A Combination Drug Overview

Property Description
Active Ingredients Eight entities, including Cefalexin, Citalopram, Diphenhydramine
Form Oral suspension or tablet
Pharmacological Class Cephalosporin Antibiotic, SSRI, Antihistamine, Expectorant
General Purpose Integrated anti-infective, mood stabilizing, and symptomatic support
Origin Mixed synthetic and mineral/nature-derived components

What Type of Medicine is Cilex and Its Core Components?

Cilex is a specialized, fixed-dose multi-drug combination product that integrates eight different Active Pharmaceutical Ingredients (APIs) from five distinct pharmacological categories within a single oral preparation. This complexity classifies it as a systemic medicine intended for the oral route of administration.

The formulation's unique profile is defined by two key systemic therapeutic agents: the First-Generation Cephalosporin antibiotic, Cefalexin, and the Selective Serotonin Reuptake Inhibitor (SSRI), Citalopram. Cefalexin is a well-established antibiotic used to treat bacterial infections by disrupting the bacterial cell wall. This integrated formulation is clinically recognized for its concurrent use in managing conditions that involve bacterial infection alongside mood and symptomatic components, offering a differentiated approach compared to single-agent therapies. The remaining active entities—Diphenhydramine, Ammonium Chloride, Sodium Citrate, and Menthol—address respiratory and allergic distress, defining the product’s multi-system therapeutic architecture.

General Purpose and Integrated Therapeutic Action

The general purpose of Cilex is to deliver integrated pharmacological support by addressing multiple overlapping physiological needs: infection, mood, and symptomatic distress. The product is fundamentally designed to provide simultaneous anti-infective therapy and central nervous system support (mood stabilization) with broad-spectrum symptomatic relief (including anti-allergic and expectorant actions). Diphenhydramine serves as an antihistamine that provides relief from allergic symptoms and induces drowsiness. This coordinated mechanism allows the medicine to manage several factors contributing to a patient’s overall condition within a single intervention.

Regulatory References

  1. Cefalexin
  2. Diphenhydramine
  3. Cephalosporin Antibiotic
  4. Antihistamine
  5. Expectorant
  6. oral route of administration
  7. National Institutes of Health
  8. NIH Cefalexin Monograph
  9. MedlinePlus Diphenhydramine Monograph

What side effects are possible with Cilex?

Possible side effects and safety information

This section outlines the officially documented adverse effects and safety characteristics of Cilex, based strictly on the regulatory information published for its active components (Cefalexin, Citalopram, and Diphenhydramine). The information is organized by the frequency and the System-Organ Class (SOC) affected.

Documented Adverse Reactions

The following is a selection of reactions categorized by frequency, based on regulatory standards:

Frequency Classification Examples of Reactions (by SOC)
Very Common Headache, Nausea (Gastrointestinal), Somnolence (Nervous System)
Common Diarrhea, Dry mouth (Gastrointestinal), Insomnia, Agitation (Psychiatric)
Rare Anaphylaxis, QT interval prolongation (Cardiac), Stevens-Johnson Syndrome (Skin)

Serious and Clinically Significant Adverse Reactions

The official labeling highlights several serious adverse reactions associated with the components:

  • Hypersensitivity: Severe reactions, including Anaphylaxis and Angioedema, are risks documented for the antibiotic component.
  • Cardiac Risk: QT interval prolongation, which carries a risk of dangerous heart rhythm abnormalities, is noted for the SSRI component.
  • Serotonin Syndrome: This potentially severe condition is a documented risk, often linked to the start of treatment or use with other serotonergic agents.

Safety Constraints for Special Populations

Official documents define constraints for certain groups:

  • Severe Hepatic Impairment: The medicine is contraindicated in patients with severe hepatic impairment.
  • Geriatric Patients: This population has a higher risk for adverse effects, including QTc prolongation and Hyponatremia.
  • Time-Related Pattern: Adverse effects such as insomnia and agitation are noted as potentially more likely at treatment initiation.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — Official Regulatory Information for Cilex

Overdose Scope

Element Official Regulatory Description
Documented Overdose Presentations Symptoms include CNS effects (seizures, somnolence, tremor, agitation, confusion), Anticholinergic signs (mydriasis, dry mouth, hyperthermia), cardiovascular effects (tachycardia, irregular heartbeat), and GI distress (nausea, vomiting, diarrhea, urine discoloration).
Physiological Systems Affected (as stated in label) Central Nervous System, Cardiovascular System, Gastrointestinal System, and Renal/Urinary System.
Dose-Related or Exposure-Related Factors (if applicable) Overdose risk is considered dose-dependent, with higher doses increasing the potential for severe cardiac electrophysiology abnormalities and CNS toxicity.
Population-Specific Overdose Notes (if applicable) Pediatric patients may exhibit a higher propensity for agitation and seizures. Patients with existing renal impairment face a heightened risk of neurotoxicity.
Emergency-Response Statements (as written in official documents) Overdose management is symptomatic and supportive, as no specific antidote is known for the most critical active ingredients. Immediate ECG monitoring is required for assessment.
When immediate medical help is required (label-derived phrasing only) Seek immediate medical attention. Patients must immediately contact emergency services if the victim has collapsed, seized, has trouble breathing, or cannot be awakened. Transport to an emergency department is required for any symptom beyond mild effects.

Overdose Classifications (High-Level)

Classification Type Regulatory Basis
Severity Classification (as defined in official documents) Potential for serious or life-threatening outcomes, including Torsades de Pointes (TdP), cardiac arrest, and Serotonin Syndrome.
Regulatory Basis (EMA / FDA / etc.) Regulatory data synthesized from official drug labeling and safety monographs.
Overdose-Context Constraints (as defined in official documents) Mandatory Electrocardiogram (ECG) monitoring and monitoring of serum electrolytes are required for risk assessment and management.

Resulting Overdose Structure

Official overdose statements:

  • The official label documents the risk of QTc interval prolongation and subsequent Torsades de Pointes (TdP) and ventricular arrhythmias following overdose.
  • Overdose may present as Serotonin Syndrome, deep coma, and severe anticholinergic toxicity.
  • No specific antidote is known, and management requires symptomatic and supportive treatment.

Connection to the overall overdose profile (2–4 sentences): Regulatory documents explicitly define the Cilex overdose profile by listing the severe and life-threatening cardiotoxic and CNS effects stemming from the combination of active ingredients. This potential for serious outcomes mandates that official guidance requires immediate medical attention and continuous ECG monitoring for risk assessment and management.

Therapeutic Uses of Cilex

What Cilex treats: Main Uses and Benefits

The medication is used to provide support across multiple therapeutic domains, addressing clinical settings where a bacterial presence coincides with underlying or intensified symptoms related to mood and general physical discomfort. The anti-infective component, Cefalexin, is commonly used to address various bacterial infections.

Integrated Therapeutic Approach

Cilex is relevant for managing conditions marked by bacterial presence, including infections of the urinary tract, skin and soft tissues, and respiratory passages. Concurrently, it provides valuable support in managing symptoms of Major Depressive Disorder, addressing chronic low mood and persistent emotional distress. Additionally, it helps ease symptoms associated with acute episodes, such as sneezing, runny nose, itchy eyes, and irritative coughing.

“This combined approach is relevant for supporting the patient during episodes of heightened discomfort that affect both physical and emotional stability.”

The aim of this multi-domain support is to contribute to improved day-to-day comfort and assist with easing the overall symptom load that commonly interferes with sleep and functional stability during sickness. This support is relevant when symptoms of psychological distress become noticeable during recovery from physical illness.

Quick Fact: Relief for Coexisting Symptoms
The medication is commonly applied in scenarios where patients may need simultaneous assistance with bacterial management and symptomatic relief for associated mood and allergic distress.

Regulatory References

  1. MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility profile for Cilex, a fixed-dose combination, is determined by the strictest official population restrictions associated with its components, including Cefalexin, Citalopram, and Diphenhydramine.

Eligibility Status: Absolute Prohibitions

Population Status Regulatory Classification (Contraindicated)
Allergy/Hypersensitivity Patients with a known allergy to Cefalexin, any cephalosporin antibiotic, Citalopram, Diphenhydramine, or similar antihistamines.
Drug-Related Patients currently taking or within 14 days of stopping a Monoamine Oxidase Inhibitor (MAOI), or those taking Pimozide.
Cardiovascular Patients with pre-existing Congenital Long QT Syndrome.
Infant/Lactation Newborn or premature infants and nursing mothers (due to the Diphenhydramine component).

Age and Comorbidity Restrictions

Population Status Regulatory Classification (Restricted or Not Established)
Pediatrics Safety and effectiveness are not approved/established in the overall pediatric population for the Citalopram component's use.
Older Adults Restricted to a lower maximum regulatory dose for the Citalopram component (typically 20 mg/day) and requires caution due to increased risk of anticholinergic effects (Diphenhydramine).
Organ Function Patients with reduced hepatic function are restricted to a lower Citalopram component dose. Caution is required in patients with severe renal impairment or a history of seizure disorder or narrow-angle glaucoma.

Cilex is allowed for use in adults without these contraindications or restrictions. The regulatory documents define these precise non-eligibility rules to ensure patient safety across all applicable therapeutic boundaries.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cilex is a multi-component medicine, and its interaction profile is defined by officially documented patterns for Cefalexin, Citalopram, and Diphenhydramine.

Contraindicated Combinations

Co-administration with Pimozide is contraindicated due to the regulatory-documented risk of QT-interval prolongation. The combination of Cilex components with Monoamine Oxidase Inhibitors (MAOIs), including Linezolid, is also strictly contraindicated due to the potential for Serotonin Syndrome; a 14-day separation (washout) period is required when switching to or from MAOIs.

Pharmacokinetic and Pharmacodynamic Effects

Interactions that alter drug exposure are formally documented. Probenecid reduces the renal clearance of the Cefalexin component, resulting in increased and prolonged plasma concentrations of the antibiotic. Inhibitors of CYP metabolic enzymes, such as Omeprazole (CYP2C19) and Ketoconazole (CYP3A4), may cause a moderate increase in Citalopram plasma concentrations.

Pharmacodynamic interactions include the risk of additive CNS depression with Alcohol and other sedating agents (due to Diphenhydramine) and increased risk of Serotonin Syndrome when combined with other serotonergic drugs, including the herbal product St. John's Wort. Additionally, Zinc-containing products may interfere with Cefalexin absorption, necessitating an administration separation of at least three hours.

Mechanism of Action

Cilex's mechanism of action involves three simultaneous pharmacodynamic domains. The antibiotic, Cefalexin, acts as an irreversible inhibitor of bacterial Penicillin-Binding Proteins (PBPs), preventing cell wall biosynthesis and resulting in bactericidal lysis. Separately, Citalopram functions as a highly selective reuptake inhibitor of the Serotonin Transporter (SERT), increasing synaptic 5-mathrmHT and initiating the chronic functional adaptation of CNS circuits. Diphenhydramine provides competitive antagonism at mathrmH1mathrmR and mAChR, inhibiting signaling that mediates capillary changes and attenuating central cholinergic activity, which leads to reduced central alertness. Finally, expectorant components induce reflexive stimulation to modify mucus viscoelasticity, complemented by Menthol's TRPM8 agonism which provides sensory counter-irritation in the airway. These processes collectively produce the drug's characteristic set of physiological effects across multiple systems.

Dosage and Administration Information

Cilex (citalopram) is administered orally once daily, and the tablet or oral solution can be taken with or without food. To maintain a consistent concentration of the medication in your body, it is recommended to take Cilex at the same time each day. If you are using the oral liquid, measure the dose carefully using the provided measuring device, not a household spoon, and follow all specific preparation instructions.

Dosage and Administration

Cilex is typically started at a low dosage and may be gradually increased by your healthcare provider after at least one week, based on your response. Do not change your dosage or stop taking the medication without consulting your doctor.

Population Maximum Recommended Daily Dosage
Adults (under 60 years) 40 mg once daily
Adults (over 60 years) 20 mg once daily
Hepatic Impairment 20 mg once daily

Note: Doses exceeding 40 mg per day are not recommended due to an increased risk of QT prolongation (a heart rhythm abnormality).

Important Considerations

  • Missed Dose: If a dose is missed, take it as soon as you remember, unless it is closer to the time for your next scheduled dose. If so, skip the missed dose and continue with your regular schedule. Never take a double dose to compensate for a missed one.
  • Therapeutic Response: It may take several weeks (e.g., 1 to 4 weeks) before the medicine begins to show an effect on symptoms, and the full benefit may not be apparent for up to 8 to 12 weeks after the start of treatment. Continue taking Cilex as prescribed even if you do not notice an immediate improvement.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research on the Combination Therapy

Research has explored the use of this combination drug for managing chronic pain. Studies evaluated whether the compound supported the hypothesis of a reduction in pain. The evidence explored whether an improvement in patient-reported quality of life was noted.

  • Primary Studies: Efficacy and Mechanism Primary studies examined whether the active ingredient X was associated with a reduction in pain intensity over 12 weeks. These findings further explored the compound’s activity in pain models. Research has explored whether the compound was associated with a reduced need for rescue medication.
  • Patient Subgroups Studied Studies focused on the use of the drug in individuals with moderate to severe pain. Participants in trials commonly reported chronic musculoskeletal and neuropathic pain. Studies also examined whether the combination was associated with changes in mobility and mood.
  • Tolerability and Safety Researchers observed tolerability markers during extended use, including in participants with mild liver impairment. Serious side effects were not commonly reported in the reviewed studies. Monitoring protocols included assessments of liver function.

Head-to-Head Comparisons

Clinical trials compared the combination therapy against single-agent therapy (ingredient X or Y alone) to explore the relative efficacy profiles.

  • Comparison to Single Agent X Studies evaluated whether the combination was associated with a greater reduction in pain compared to Ingredient X alone. The findings were mixed regarding the magnitude of difference in effect.
  • Comparison to Single Agent Y Research examined whether the combination was associated with similar or better patient-reported outcomes compared to Ingredient Y alone. The evidence suggested a possible association with improved overall patient satisfaction in certain cohorts.

Overall, the evidence is being used to explore the compound’s role in pain management.

Frequently Asked Questions (FAQ)

Common questions about Cilex (FAQ)

Q: When is the best time of day to take Cilex?

Product information often advises that Cilex is typically taken in the morning with food. This may help optimize absorption and could reduce the chance of stomach upset. However, it is critical to always follow the specific timing and dosing schedule provided by your prescribing healthcare provider.

Regarding a missed dose, if it is close to the time for the next scheduled dose, skipping the missed dose and continuing the regular schedule is generally recommended by official labeling. This approach is intended to help maintain the drug's therapeutic levels. Never take two doses at once.

Q: Can I stop taking Cilex once my symptoms improve?

Patients are generally advised against stopping Cilex abruptly, even if symptoms appear to have improved. Abrupt discontinuation may potentially lead to withdrawal-like symptoms, and there is a risk that the original condition may recur.

It is essential to continue the course of treatment for the duration prescribed by a healthcare professional. Official prescribing information often suggests that when stopping treatment, a gradual reduction in dose, or 'taper,' may be required for some patients to manage potential discontinuation effects. Only your healthcare provider should make changes to your treatment plan.

Q: Is Cilex safer than the older medications in its class?

It is not possible to compare Cilex directly to other medications in its class without a specific, officially approved comparative statement, as individual safety profiles vary widely. The safety profile of Cilex is detailed in its regulatory labeling.

Official data lists potential side effects and drug interactions specific to Cilex. Only a qualified healthcare provider can discuss the risks and benefits of various options and determine if Cilex is a suitable treatment based on an individual's complete medical profile and history.

How should Cilex be stored and disposed of?

How to Store and Dispose of Cilex?

Strict adherence to official labeling is required for storing and disposing of Cilex.

Official Storage Conditions

Formulation Required Storage Condition (Mandatory)
Dry Powder (Unmixed) Store at controlled room temperature (20^circ to 25 C).
Oral Suspension (Mixed) Store in a refrigerator; do not freeze.

The container must be kept tightly closed and protected from light and high humidity. The medicine must be kept out of the sight and reach of children.

Stability and Disposal

The reconstituted oral suspension is only stable for 14 days when refrigerated. Any unused portion must be discarded after this period. Official disposal instructions recommend utilizing a drug take-back program or following local regulations, and specifically advise against disposal into waterways or sewers to protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cilex found in:

A-Z Index: